Inhibition of periostin expression protects against the development of renal inflammation and fibrosis

dc.contributor.authorMael-Ainin, Mouna
dc.contributor.authorAbed, Ahmed
dc.contributor.authorConway, Simon J.
dc.contributor.authorDussaule, Jean-Claude
dc.contributor.authorChatziantoniou, Christos
dc.contributor.departmentDepartment of Pediatrics, IU School of Medicineen_US
dc.date.accessioned2016-06-21T16:54:20Z
dc.date.available2016-06-21T16:54:20Z
dc.date.issued2014-08
dc.description.abstractIncreased renal expression of periostin, a protein normally involved in embryonic and dental development, correlates with the decline of renal function in experimental models and patient biopsies. Because periostin has been reported to induce cell differentiation, we investigated whether it is also involved in the development of renal disease and whether blocking its abnormal expression improves renal function and/or structure. After unilateral ureteral obstruction in wild-type mice, we observed a progressive increase in the expression and synthesis of periostin in the obstructed kidney that associated with the progression of renal lesions. In contrast, mice lacking the periostin gene showed less injury-induced interstitial fibrosis and inflammation and were protected against structural alterations. This protection was associated with a preservation of the renal epithelial phenotype. In vitro, administration of TGF-β to renal epithelial cells increased the expression of periostin several-fold, leading to subsequent loss of the epithelial phenotype. Furthermore, treatment of these cells with periostin increased the expression of collagen I and stimulated the phosphorylation of FAK, p38, and ERK 42/44. In vivo delivery of antisense oligonucleotides to inhibit periostin expression protected animals from L-NAME-induced renal injury. These data strongly suggest that periostin mediates renal disease in response to TGF-β and that blocking periostin may be a promising therapeutic strategy against the development of CKD.en_US
dc.identifier.citationMael-Ainin, M., Abed, A., Conway, S. J., Dussaule, J.-C., & Chatziantoniou, C. (2014). Inhibition of Periostin Expression Protects against the Development of Renal Inflammation and Fibrosis. Journal of the American Society of Nephrology : JASN, 25(8), 1724–1736. http://doi.org/10.1681/ASN.2013060664en_US
dc.identifier.issn1533-3450en_US
dc.identifier.urihttps://hdl.handle.net/1805/10065
dc.language.isoen_USen_US
dc.publisherAmerican Society of Nephrologyen_US
dc.relation.isversionof10.1681/ASN.2013060664en_US
dc.relation.journalJournal of the American Society of Nephrology: JASNen_US
dc.rightsPublisher Policyen_US
dc.sourcePMCen_US
dc.subjectCell Adhesion Moleculesen_US
dc.subjectphysiologyen_US
dc.subjectNephritisen_US
dc.subjectetiologyen_US
dc.subjectNephrosclerosisen_US
dc.titleInhibition of periostin expression protects against the development of renal inflammation and fibrosisen_US
dc.typeArticleen_US
ul.alternative.fulltexthttp://www.ncbi.nlm.nih.gov/pmc/articles/PMC4116056/en_US
Files
Original bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
Inhibition of Periostin Expression.pdf
Size:
579.22 KB
Format:
Adobe Portable Document Format
Description:
PDF of PMC printer-friendly version
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.88 KB
Format:
Item-specific license agreed upon to submission
Description: